The Texas Rangers have confirmed their decision to bring back Jordan Montgomery, a key member of their 2023 World Series championship team, following his recent elbow surgery. According to sources, the team has agreed to a one-year contract with the left-handed pitcher, who previously led the team to victory in the 2023 World Series. The deal, which is reportedly valued at $1.25 million, marks a significant move by the Rangers to rebuild their pitching staff after a disappointing 2025 season.
Montgomery's return to the team comes after he underwent a second Tommy John surgery in April 2024, following his initial procedure in 2018. This makes him one of the few pitchers in Major League Baseball to have required two such surgeries, a fact that has raised questions about his long-term recovery and potential impact on the team's performance.
The Rangers' decision to sign Montgomery reflects their strategic focus on securing experienced talent from past championship runs. The team has been under pressure to improve their pitching department after a series of injuries and inconsistent performances throughout the 2025 season. Montgomery's presence could provide stability and a familiar face for the team, especially given his role in the 2023 World Series.
However, Montgomery's return is not without controversy. His second Tommy John surgery has delayed his readiness for the 2026 season, with his rehabilitation process expected to take at least six months. This delay could impact the team's ability to field a competitive roster in the early stages of the season.
While the Rangers have shown confidence in Montgomery's ability to contribute, the team faces a critical challenge in balancing the need for immediate results with the reality of lengthy recovery timelines. Montgomery's experience and leadership could be invaluable, but the risk of extended absence due to further complications remains a concern.
The decision to sign Montgomery highlights the financial and strategic complexities of rebuilding a championship-caliber team. Teams often face tough choices when dealing with players who have experienced multiple health issues, as the cost of repeated surgeries and rehabilitation can be substantial.
As the 2026 season approaches, the Rangers' focus shifts to balancing short-term needs with long-term planning. Montgomery's return could be a pivotal moment for the team, but it also underscores the challenges of maintaining a competitive edge in a highly competitive league.
